Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran
- 29 April 2005
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 19 (7) , 709-716
- https://doi.org/10.1097/01.aids.0000166094.24069.72
Abstract
This study was conducted to identify the prevalence of and potential risk factors for HIV-1 infection among drug users visiting drug treatment centers in Tehran, Iran. Cross-sectional quantitative study. Between October 2003 and May 2004, drug users who visited three public drug treatment centers in Tehran were interviewed and information about their sociodemographics, drug use characteristics, incarceration history, sexual history, and HIV/AIDS knowledge and risk perception were collected. Specimens of oral mucosal transudate were then collected from participants to be tested for HIV-1 antibodies. Logistic regression analysis was conducted on the association between the demographic and behavioral factors with HIV-1 infection. Overall, 611 (588 male and 23 female) drug users participated in the study. Among male injectors with HIV-1 prevalence of 15.2%, a history of shared injection inside prison [adjusted odds ratio (OR), 12.37; 95% confidence interval (CI), 2.94–51.97] was the main factor associated with HIV-1 infection. Among those who reported no history of injecting drug use, HIV-1 prevalence was 5.4%, and lack of condom use during sex was significantly associated with the infection (adjusted OR, 3.42; 95% CI, 1.25–9.36). HIV-1 infection is already prevalent among drug users in Tehran, Iran and shared injection inside prison has been revealed to be a particular risk factor for HIV-1 infection among injecting drug users. Harm reduction programs which have been started in Iran should be urgently expanded particularly in correctional settings and strengthened by condom use promotion to prevent sexual acquisition or transmission of HIV-1 among drug users.Keywords
This publication has 15 references indexed in Scilit:
- Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control studyBMJ, 2003
- Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, ThailandAIDS, 2001
- HIV transmission in a prison system in an Australian StateThe Medical Journal of Australia, 1999
- History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in BerlinInternational Journal of Epidemiology, 1997
- Evaluation of a System Using Oral Mucosal Transudate for HIV-1 Antibody Screening and Confirmatory TestingJAMA, 1997
- Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec CityAIDS, 1996
- Outbreak of HIV infection in a Scottish prisonBMJ, 1995
- Methadone Maintenance and the Likelihood of Risky Needle-SharingInternational Journal of the Addictions, 1995
- HIV epidemiology and risk behavior promoting HIV transmission in Austrian prisonsEuropean Journal of Epidemiology, 1994
- Methadone Maintenance and Needle/Syringe SharingInternational Journal of the Addictions, 1993